Prior to joining Volastra, Celia worked at Inspirna as a senior scientist and principal scientist of translational medicine. There, she designed and executed the biomarker strategy to support early clinical development of 2 first-in-class drugs targeting NSCLC and CRC. Celia received her undergraduate degree in Pharmacology and her Ph.D. in Neurobiology from University of Valencia in Spain. Prior to joining Inspirna, she was a postdoctoral fellow at Memorial Sloan Kettering Cancer Center where she studied the role of microRNAs in glioma. She has led numerous research projects that have been published in Nature, Nature Neuroscience and Cell. Celia was an EMBO and NYSTEM fellow recipient and was given the award for the best MSKCC Postdoctoral Research of the Year.